Pharmacokinetics and Safety of ORF Tablets in Pediatric Patients

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2010
The purpose of this study is to characterize the pharmacokinetics (PK) of single-dose ORF tablets in pediatric patients aged 6 to 16 years, inclusive.
Epistemonikos ID: c2420dd1da33c88a4c87df789f5cb006bd0b2166
First added on: May 05, 2024